Therapeutic options for the treatment of tinea capitis: Griseofulvin versus fluconazole

Journal of Dermatological Treatment

Volumn 16, Issue 1, 2005, Pages 43-46

  Dastghaib, L ^a   Azizzadeh, M ^a,b   Jafari, P ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Fluconazole; Griseofulvin; Tinea capitis; Treatment

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; FEMALE; FUNGUS ISOLATION; HUMAN; MALE; MICROSPORUM CANIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TINEA CAPITIS; TRICHOPHYTON VERRUCOSUM; TRICHOPHYTON VIOLACEUM;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUCONAZOLE; GRISEOFULVIN; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TINEA CAPITIS; TREATMENT OUTCOME;

EID: 14144249810     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630510025932     Document Type: Article

References (16)

1. Elewski BE. Cutaneous mycoses in children. Br J Dermatol 1996;134(suppl46):7-11.
2. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000;42:1-20.
3. Gupta A, Sauder D, Shear N. Antifungal agents: an overview. Part 1. J Am Acad Dermatol 1994;30:677-98.
4. Friedlander SF. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. Pediatr Infect Dis J 1999;18:205-10.
5. Degreef H, Dedoncker P. Current therapy of dermatophytosis. J Am Acad Dermatol 1994;31(suppl):25-30.
6. Sheppard D, Lampiris HW. Antifungal agents. In: Katzung BG, editor. Basic and clinical pharmacology. 8th ed., California: McGraw-Hill, 2001:817-20.
7. Yeates R, Laufen H, Zimmermann T, Scharpf F. Accumulation of fluconazole in scalp hair. J Clin Pharmacol 1998;35:135-43.
8. Solomon BA, Collins R, Sharma R, Silverberg N, Jain AR, Sedgh J, et al. Fluconazole for the treatment of tinea capitis. J Am Acad Dermatol 1997;37:274-5.
9. Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafin, itraconazole, and fluconazole. Pediatr Dermatol 2001;18(5):433-8.
10. Gupta AK, Adam P, Hofstader SL, Lynde CW, Taborda P, Taborda V, et al. Intermittent short-duration therapy with fluconazole is effective in the treatment of tinea capitis. Br J Dermatol 1999;141(2):304-6.
11. Gupta AK, Dlova N, Taborda P, Morar N, Taborda V, Lynde CW, et al. Once weekly fluconazole is effective in the treatment of tinea capitis. A prospective, multicentre study. Br J Dermatol 2000;142(5):965-8.
12. Williams J, Honig P, McGinley K, Leyden J. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics 1995;96:265-7.
13. Fuller LC, Child FC, Midgley G, Higgins EM. Scalp ringworm in south-east London and an analysis of a cohort of patients from a pediatric dermatology department. Br J Dermatol 2003;148:985-8.
14. Chadeganipour M, Shadzi S, Dehghan P, Movehed M. Prevalence and etiology of dermatophytoses in Isfahan, Iran. Mycoses 1997;40(7-8):321-4.
15. Omidynia E, Farshchian M, Sadjjadi M, Zamanian A, Rashidpouraei R. A study of dermatophytoses in Hamadan, the governmentship of west Iran. Mycopathologia 1996;133(1):9-13.
16. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol 2000;143:53-8.